Cargando…
Antiepileptic drug treatment of rolandic epilepsy and Panayiotopoulos syndrome: clinical practice survey and clinical trial feasibility
BACKGROUND: The evidence base for management of childhood epilepsy is poor, especially for the most common specific syndromes such as rolandic epilepsy (RE) and Panayiotopoulos syndrome (PS). Considerable international variation in management and controversy about non-treatment indicate the need for...
Autores principales: | Mellish, Louise C, Dunkley, Colin, Ferrie, Colin D, Pal, Deb K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283698/ https://www.ncbi.nlm.nih.gov/pubmed/25202134 http://dx.doi.org/10.1136/archdischild-2013-304211 |
Ejemplares similares
-
Antiepileptic Drug of Levetiracetam Decreases Centrotemporal Spike-Associated Activation in Rolandic Epilepsy
por: Zhang, Qirui, et al.
Publicado: (2018) -
Case Report: Four Cases of Panayiotopoulos Syndrome Evolving to Juvenile Myoclonic Epilepsy
por: Enoki, Hideo, et al.
Publicado: (2020) -
Todd Paralysis in Rolandic Epilepsy
por: Striano, Pasquale, et al.
Publicado: (2015) -
Reply to: Is a microRNA‐328 binding site in PAX6 associated with Rolandic epilepsy?
por: Strug, Lisa J., et al.
Publicado: (2017) -
Clinical profile of patients with rolandic epilepsy at a clinic in rural Maharashtra
por: Sable, Sunil, et al.
Publicado: (2021)